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background:  Left ventricular (LV) reverse remodeling (RR) is often associated with reduced adverse events. This study evaluated the 
extent and impact of RR after transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS).
methods:  We analyzed patients with at least moderate LV dilation (end-diastolic volume index, EDVi ≥ 87 ml/m2) for RR (EDVi decrease ≥ 
5ml/m2) between baseline and 30 days after TAVR. Event rates at 1 year were compared in RR and no RR patients.
results:  Of the 2358 patients, 301 (12.8%) had at least moderate LV dilation and paired baseline and 30-day LV volumes. RR occurred in 
209 patients (69.4%). At baseline, those with RR had larger EDVi (p=0.02) and higher peak and mean AS gradients (p=0.007; 0.004), but 
similar end-systolic volume index (ESVi, p=0.33) and ejection fraction (EF, p=0.09). EDVi and ESVi significantly decreased in patients with 
RR (both p<0.0001), but increased in those without RR (Table). A significantly greater increase in EF occurred with RR: +3.94 vs +1.41%, 
p=0.009. Moderate-severe paravalvular aortic regurgitation and mitral regurgitation were more likely at 1 year in patients with no RR (both 
p=0.02), but rates of all-cause death (p=0.56), cardiac death (p=0.72), and repeat hospitalization (p=0.38) were similar.
Conclusion:  Although LV dilation is uncommon in severe AS, such patients demonstrate significant RR after TAVR. However, this did not 
correlate with reduced events at 1 year suggesting that RR may not be prognostic in this population.
Table:
NO REVERSE REMODELING
(n=92)
REVERSE REMODELING
(n=209) [Δ No RR] - [Δ RR]
BASELINE 30 DAYS Δ p-value BASELINE 30 DAYS Δ p-value Δ - Δ(95% CI) p-value
End-
Diastolic 
Volume 
Index (ml/
m2)
102.70 ± 14.91 112.69 ± 18.80
+9.99
± 11.77 <0.0001 107.54 ± 18.48
74.85 ± 
21.56
-32.69 
± 20.06 <0.0001
42.69
(38.27-
47.10)
<0.0001
End-
Systolic 
Volume 
Index (ml/
m2)
65.98 ± 19.31 69.00 ± 21.81
+3.02
± 10.64 0.0121 64.03 ± 21.55
42.97 ± 
18.23
-21.05
± 16.89 <0.0001
24.07
(20.29-
27.85)
<0.0001
Ejection 
Fraction 
(%)
38.53 ± 12.60 39.94 ± 11.64
+1.41
± 6.93 0.0329 41.26 ± 13.21
45.20 ± 
11.98
+3.94
± 9.03 <0.0001
2.53
(0.45-
4.61)
0.009
